Granules India Q2 FY24 PAT drops 30% at Rs. 102 Cr
Sales in the US region grew well, partially offset by the decline in the LATAM and European regions
Sales in the US region grew well, partially offset by the decline in the LATAM and European regions
European operations' revenue grew 58.4% to Rs 599.7 crore
he company posted total income during Q2 FY24 at Rs. 12.86 crore
US business grew by +12.8% YoY
General Medicine grows 5% and Vaccines 10% led by Shingrix
Dr. Reddy’s maintains that the allegations against it lack merit and will vigorously defend the litigation
The collaboration brings a seamless digital experience to more formulators worldwide
PhytoSquene now available for clinical and commercial use
This product will be manufactured at Lupin’s Pithampur facility in India
Subscribe To Our Newsletter & Stay Updated